Home » ABBOTT RECEIVES FDA 510K CLEARANCE TO MARKET FREESTYLE FREEDOM BLOOD GLUCOSE MONITORING SYSTEM
ABBOTT RECEIVES FDA 510K CLEARANCE TO MARKET FREESTYLE FREEDOM BLOOD GLUCOSE MONITORING SYSTEM
Abbott Diabetes Care announced
today it has received 510(k) clearance from the U.S. Food and Drug Administration
to market its FreeStyle Freedom blood glucose monitoring system for consumer use.
PR
Newswire
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May